Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2017 · 10-Q
Revenue$591.00K$591.00K−55.7% vs Q1 2016 Net Income-$7.54M-$7.54MN/M vs Q1 2016 EPS Diluted-$0.33-$0.33N/M vs Q1 2016 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flow-$4,827,000N/M Free Cash Flowderived-$4,832,000N/M Margins · derivedGross margin-21.2%−78.6 pt vs Q1 2016
Operating margin-1206.3%−823.9 pt vs Q1 2016
Net margin-1276.5%−876.0 pt vs Q1 2016
ended Mar 31, 2017 · filed May 12, 2017 · 42 d after period end